Hepatitis B and C Viruses and Biologics

Skin Therapy Letter-Family Practice Edition

Parbeer Grewal¹  Ravina Sanghera² 

[1] 1Division of Dermatology, Department of Medicine, University of Calgary, Calgary, AB, Canada;2Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, AB, Canada

关键词: adalimumab;    biologic;    etanercept;    hepatitis B virus;    hepatitis C virus;    infliximab;    ustekinumab;   

学科分类：医学（综合）

来源: Skin Therapy Letter-Family Practice Edition

【 摘 要 】

Hepatitis B virus (HBV) and hepatitis C virus (HCV) are common, worldwide viral illnesses that potentially impact the clinician’s ability to manage patients with immunosuppressive medications such as biological therapy. In light of recent literature reviews, patients with HBV and HCV should be referred to a hepatologist or infectious disease expert prior to initiation of biological therapy. 

【 授权许可】

CC BY